Suppr超能文献

D-二聚体与血小板计数比值作为预测乙肝相关失代偿期肝硬化预后的新指标。

D-dimer-to-platelet count ratio as a novel indicator for predicting prognosis in HBV-related decompensated cirrhosis.

作者信息

He Xia, Ding QiuMing

机构信息

Department of Clinical Laboratory, Shengzhou People's Hospital, Shengzhou Branch of the First Affiliated Hospital of Zhejiang University, Shengzhou, 312400, China.

出版信息

Heliyon. 2024 Feb 20;10(5):e26585. doi: 10.1016/j.heliyon.2024.e26585. eCollection 2024 Mar 15.

Abstract

BACKGROUND

Hepatitis B virus-related decompensated cirrhosis (HBV-DC) is a critical illness with a low survival rate. Timely identification of prognostic indicators is crucial for risk stratification and personalized management of patients. The present study aimed to investigate the potential of the D-dimer-to-platelet count ratio (DPR) as a prognostic indicator for HBV-DC.

METHODS

A retrospective review of medical records was conducted for 164 patients diagnosed with HBV-DC. Baseline clinical and laboratory characteristics were extracted for analysis. The endpoint was 30-day mortality. Disease severity was assessed by the Model for End-stage Liver Disease (MELD) score. A multivariate logistic regression model and receiver operating characteristic curve analysis (ROC) were used to evaluate the predictive value of DPR for mortality.

RESULTS

During the 30-day follow-up period, 30 (18.3%) patients died. Non-survivors exhibited significantly higher DPR values than survivors, and a high DPR had a strong association with increased mortality. Importantly, DPR was identified as an independent risk factor for mortality in HBV-DC patients after adjustments for confounding factors (Odds ratio = 1.017; 95% Confidence interval, 1.006-1.029; p = 0.003). The cut-off value of DPR as a predictor of mortality was>57.6 (sensitivity = 57%, specificity = 86%, p < 0.001). The area under ROC curve for DPR for 30-day mortality was 0.762, comparable to the MELD score (p = 0.100). Furthermore, the combined use of DPR and MELD score further increased the area under the ROC curve to 0.897.

CONCLUSION

Elevated DPR was demonstrated to have a correlation with unfavorable outcomes in HBV-DC patients, suggesting its potential utility as an effective biomarker for assessment of prognosis in these patients.

摘要

背景

乙型肝炎病毒相关失代偿期肝硬化(HBV-DC)是一种病死率较低的危重病。及时识别预后指标对于患者的风险分层和个体化管理至关重要。本研究旨在探讨D-二聚体与血小板计数比值(DPR)作为HBV-DC预后指标的潜力。

方法

对164例诊断为HBV-DC的患者进行病历回顾性分析。提取基线临床和实验室特征进行分析。终点为30天死亡率。采用终末期肝病模型(MELD)评分评估疾病严重程度。采用多因素逻辑回归模型和受试者工作特征曲线分析(ROC)评估DPR对死亡率的预测价值。

结果

在30天随访期内,30例(18.3%)患者死亡。非存活者的DPR值显著高于存活者,高DPR与死亡率增加密切相关。重要的是,在调整混杂因素后,DPR被确定为HBV-DC患者死亡的独立危险因素(比值比=1.017;95%置信区间,1.006-1.029;P=0.003)。DPR作为死亡率预测指标的截断值>57.6(敏感性=57%,特异性=86%,P<0.001)。DPR预测30天死亡率的ROC曲线下面积为0.762,与MELD评分相当(P=0.100)。此外,DPR与MELD评分联合使用可进一步将ROC曲线下面积提高至0.897。

结论

DPR升高与HBV-DC患者不良预后相关,提示其可能作为评估这些患者预后的有效生物标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验